Zendal Group | Biotechnology and pharmacy for human and animal health

Scientific excellence applied to Biotechnology and Pharmacy for human and animal healthcare.

ZENDAL GROUP

Research, development, manufacturing
and marketing.

Counting on more than 30 years of achievements, with progress that demonstrates our experience and our values in the field of healthcare.

OUR BUSINESS

Innovation and Science are the pillars of our business

COVID Projects

At Zendal we work towards swiftly developing solutions to combat the coronavirus illness utilising the scientific capabilities and manufacturing facilities of our subsidiary companies Biofabri and CZ Vaccines.

PRESS ROOM

Latest news

18 · 03 · 2025ZENDAL receives EMA recommendation for its vaccine against EHD

27 · 02 · 2025Biofabri and IAVI announce first vaccinations in the IMAGINE clinical trial, a large-scale safety and efficacy trial of the tuberculosis vaccine candidate MTBVAC

21 · 01 · 2025Zendal supplied 42 million doses of bluetongue vaccine in Europe during 2024.

Join our team

At Zendal we count on a team of more than 650 staff that make it possible to create efficient biological products for human and animal healthcare.

ZENDAL GROUP REWARDS TALENT

International Zendal Awards

Since 2019 we have launched the International Zendal Awards in Biotechnological Research, Knowledge Transfer and Social Innovation.

MORE INFORMATION